Costs and effects in therapy for acute coranary syndromes: The case of abciximab in high- risk patients undergoing percutaneous translumial coranary angioplasty in the EPIC study

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions